Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$3.07
-0.170 (-5.25%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $2.94 $3.73 Friday, 10th May 2024 CLRB stock ended at $3.07. This is 5.25% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 6.56% from a day low at $3.05 to a day high of $3.25.
90 days $2.94 $4.45
52 weeks $1.36 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Jan 26, 2022 $0.560 $0.600 $0.550 $0.550 267 200
Jan 25, 2022 $0.500 $0.580 $0.500 $0.550 422 100
Jan 24, 2022 $0.550 $0.550 $0.500 $0.530 423 400
Jan 21, 2022 $0.600 $0.600 $0.530 $0.540 560 200
Jan 20, 2022 $0.610 $0.630 $0.590 $0.590 107 000
Jan 19, 2022 $0.650 $0.670 $0.590 $0.610 538 300
Jan 18, 2022 $0.690 $0.690 $0.630 $0.660 137 300
Jan 14, 2022 $0.680 $0.700 $0.660 $0.700 146 900
Jan 13, 2022 $0.710 $0.730 $0.680 $0.700 167 300
Jan 12, 2022 $0.690 $0.720 $0.670 $0.710 372 100
Jan 11, 2022 $0.700 $0.720 $0.680 $0.700 130 600
Jan 10, 2022 $0.690 $0.720 $0.660 $0.700 189 700
Jan 07, 2022 $0.660 $0.700 $0.650 $0.690 339 900
Jan 06, 2022 $0.700 $0.700 $0.640 $0.650 393 900
Jan 05, 2022 $0.730 $0.730 $0.670 $0.700 289 700
Jan 04, 2022 $0.727 $0.730 $0.690 $0.705 117 217
Jan 03, 2022 $0.720 $0.720 $0.678 $0.710 269 825
Dec 31, 2021 $0.679 $0.730 $0.660 $0.664 695 413
Dec 30, 2021 $0.690 $0.720 $0.670 $0.700 558 672
Dec 29, 2021 $0.690 $0.716 $0.639 $0.680 713 745
Dec 28, 2021 $0.710 $0.716 $0.673 $0.700 472 630
Dec 27, 2021 $0.690 $0.745 $0.670 $0.720 656 104
Dec 23, 2021 $0.629 $0.700 $0.625 $0.700 734 564
Dec 22, 2021 $0.630 $0.676 $0.630 $0.655 221 041
Dec 21, 2021 $0.631 $0.680 $0.630 $0.665 279 805
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT